UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Computational Psychiatry

Neuron (Cambridge, Mass.), 2014-11, Vol.84 (3), p.638-654

2014

Link zum Volltext

Verfügbarkeit prüfen

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Neuron (Cambridge, Mass.), 2019-04, Vol.102 (1), p.75-90

2019

Link zum Volltext

Verfügbarkeit prüfen

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Nature medicine, 2016-03, Vol.22 (3), p.238-249

2016

Link zum Volltext

Verfügbarkeit prüfen

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

World psychiatry, 2020-02, Vol.19 (1), p.15-33

2020

Link zum Volltext

Verfügbarkeit prüfen

Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond

Biological psychiatry (1969), 2013-06, Vol.73 (12), p.1133-1141

2013

Link zum Volltext

Verfügbarkeit prüfen

Psychiatric Disorders: Diagnosis to Therapy

Cell, 2014-03, Vol.157 (1), p.201-214

2014

Link zum Volltext

Verfügbarkeit prüfen

Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective

Biological psychiatry (1969), 2017-05, Vol.81 (10), p.874-885

2017

Link zum Volltext

Verfügbarkeit prüfen

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

The New England journal of medicine, 2020-04, Vol.382 (16), p.1497-1506

2020

Link zum Volltext

Verfügbarkeit prüfen

Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study

The Lancet. Psychiatry, 2018-09, Vol.5 (9), p.739-746

2018

Link zum Volltext

Verfügbarkeit prüfen

Lower synaptic density is associated with depression severity and network alterations

Nature communications, 2019-04, Vol.10 (1), p.1529-1529, Article 1529

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of default network deactivation in cognition and disease

Trends in cognitive sciences, 2012-12, Vol.16 (12), p.584-592

2012

Link zum Volltext

Verfügbarkeit prüfen

Searching for Cross-diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders

Biological psychiatry (1969), 2017-05, Vol.81 (10), p.848-861

2017

Link zum Volltext

Verfügbarkeit prüfen

How mental health care should change as a consequence of the COVID-19 pandemic

The Lancet. Psychiatry, 2020-09, Vol.7 (9), p.813-824

2020

Link zum Volltext

Verfügbarkeit prüfen

Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience

Brain research, 2009-10, Vol.1293, p.13-23

2009

Link zum Volltext

Verfügbarkeit prüfen

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

Nature reviews. Drug discovery, 2008-05, Vol.6 (5), p.426-437

2008

Link zum Volltext

Verfügbarkeit prüfen

A Quantitative Meta-Analysis of Neurocognitive Functioning in Posttraumatic Stress Disorder

Psychological bulletin, 2015-01, Vol.141 (1), p.105-140

2015

Link zum Volltext

Verfügbarkeit prüfen

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS

Depression and anxiety, 2016-08, Vol.33 (8), p.689-697

2016

Link zum Volltext

Verfügbarkeit prüfen

Ketamine as a promising prototype for a new generation of rapid-acting antidepressants

Annals of the New York Academy of Sciences, 2015-05, Vol.1344 (1), p.66-77

2015

Link zum Volltext

Verfügbarkeit prüfen

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

eLife, 2018-10, Vol.7

2018

Link zum Volltext

Verfügbarkeit prüfen

A Meta-Analysis of D-Cycloserine and the Facilitation of Fear Extinction and Exposure Therapy

Biological psychiatry (1969), 2008-06, Vol.63 (12), p.1118-1126

2008

Link zum Volltext

Verfügbarkeit prüfen

The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder

Annual review of pharmacology and toxicology, 2019-01, Vol.59, p.171

2019

Link zum Volltext

Verfügbarkeit prüfen

Toward Illness Phase–Specific Pharmacotherapy for Schizophrenia

Biological psychiatry (1969), 2015-12, Vol.78 (11), p.738-740

2015

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin

Neuropsychopharmacology (New York, N.Y.), 2020-05, Vol.45 (6), p.990-997

2020

Link zum Volltext

Verfügbarkeit prüfen

It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group

Biological psychiatry, 2017-10, Vol.82 (7), p.e51-e59

2017

Link zum Volltext

Verfügbarkeit prüfen

Altered global brain signal in schizophrenia

Proceedings of the National Academy of Sciences - PNAS, 2014-05, Vol.111 (20), p.7438-7443

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 853

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(783)
Mit Volltextzugriff
(740)

Publikationsform

Artikel
(818)
Buchkapitel
(17)
Reviews
(13)
Berichte
(4)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(605)
Life Sciences & Biomedicine
(580)
Humans
(539)
Psychiatry
(425)
Male
(334)
Adult
(300)
Female
(292)
Neurosciences
(275)
Neurosciences & Neurology
(272)
Biological And Medical Sciences
(216)
Medical Sciences
(207)
Middle Aged
(188)
Psychology. Psychoanalysis. Psychiatry
(166)
Psychopathology. Psychiatry
(139)
Ptsd
(138)
Adult And Adolescent Clinical Studies
(119)
Pharmacology & Pharmacy
(110)
Schizophrenia
(109)
Adults
(96)
Veterans
(83)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Computational Psychiatry

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond

Psychiatric Disorders: Diagnosis to Therapy

Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study

Lower synaptic density is associated with depression severity and network alterations

The role of default network deactivation in cognition and disease

Searching for Cross-diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders

How mental health care should change as a consequence of the COVID-19 pandemic

Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

A Quantitative Meta-Analysis of Neurocognitive Functioning in Posttraumatic Stress Disorder

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS

Ketamine as a promising prototype for a new generation of rapid-acting antidepressants

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

A Meta-Analysis of D-Cycloserine and the Facilitation of Fear Extinction and Exposure Therapy

The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder

Toward Illness Phase–Specific Pharmacotherapy for Schizophrenia

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin

It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group

Altered global brain signal in schizophrenia

Suchergebnisse filtern